
September 16, 2015 Research and Development evergreening, intellectual property, patent
September 16, 2015 Research and Development AMR, Antibiotics, Jim O'Neill, O'Neill review, antimicrobial resistance, drug development

September 16, 2015 Research and Development AstraZeneca, EASD, European Association for the Study of Diabetes, Forxiga, dapagliflozin, exenatide, real world data, real world evidence

September 14, 2015 Medical Communications, Research and Development, Sales and Marketing Michael MacLean, PureTech Health

September 14, 2015 Research and Development Cancer, Cancer Drugs Fund, NHS, clinical trials, cuts, oncology

September 11, 2015 Research and Development AstraZeneca, Cambridge, Cancer, Cancer Research UK, MedImmune, R&D, george freeman

September 11, 2015 Medical Communications, Research and Development AMRA, Pfizer, UK Biobank, med tech, metabolic disease, obesity

September 11, 2015 Research and Development, Sales and Marketing Actelion, Shire, ZS Pharma, mergers and acquisitions

September 10, 2015 Manufacturing and Production, Research and Development EM Imaging, Optometry, ophthalmology

September 10, 2015 Research and Development Gilead, HIV, PrEP, Truvada, pre-exposure prophylaxis treatment, sexually transmitted infections

September 9, 2015 Research and Development Autumn spending review, George Osborne, R&D, government, research, research and development, research funding

September 9, 2015 Research and Development Alzheimer's disease, Biogen, Neurimmune, aducanumab, neurology

September 9, 2015 Research and Development COPD, GSK, Revlar, asthma, breo, clinical trial, phase III

September 9, 2015 Medical Communications, Research and Development Dr Michael Koslowski, Mission Therapeutics

September 9, 2015 Research and Development Cancer, Yabao Pharmaceutical